Trial · NCT02183688
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Calculated time to 50% pain relief, based on the pain intensity evaluated on a visual analogue scale (VAS) | 30 min., 1, 2, 3 and 4 hours after administration of the study medication | |
| Secondary | Percentage of patients with 50 % pain relief, evaluated on a VAS | At least 2 hours after administration of the study medication | |
| Secondary | Percentage of patients with 50 % pain relief, evaluated on a VAS | At least 30 min., 1, 3, and 4 hours after administration of the study medication | |
| Secondary | Pain intensity, evaluated on a VAS | 30 min., 1, 2, 3 and 4 hours after administration of the study medication | |
| Secondary | Ratio of weighted sum of pain intensity difference scores to maximum achievable sum of pain intensity differences (%SPIDweighted), evaluated on a VAS | Up to the end of the study | |
| Secondary | Extent of impairment of daily activities, evaluated on a 4-grade verbal scale (VRS) | Before, 30 min., 1, 2, 3 and 4 hours after administration of study drug | |
| Secondary | Duration of headache | Up to 48 hours after onset of each headache episode | |
| Secondary | Global assessment of efficacy by the patient, evaluated on a 4-grade VRS | Within 12 hours after study drug administration | |
| Secondary | Global assessment of tolerability by the patient, evaluated on a 4-grade VRS | Within 12 hours after study drug administration | |
| Secondary | Number of patients with adverse events | Up to the end of the study | |
| Secondary | Global assessment of tolerability by the investigator, evaluated on a 4-grade VRS | After each administration of study drug during the treatment phase |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02183688/registered